D-0753-2021 Class II Terminated
FDA drug recall D-0753-2021 was initiated by Zydus Pharmaceuticals (USA) Inc on Aug 13, 2021 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle The recall status is terminated (terminated Apr 3, 2023). Affected quantity: 2880 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 25, 2021
- Initiation Date
- Aug 13, 2021
- Termination Date
- Apr 3, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2880 bottles
Product description
Carvedilol Tablets, USP 25 mg, 500 Tablets bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 0853, NDC 68382-095-05
Reason for recall
Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle
Distribution pattern
Nationwide in the US
Code information
Z006279, exp 12/31/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0753-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026